OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Advance planning is essential to ensure a reliable supply for parenteral drug packaging
Consistency, robustness, and API-excipient understanding are essential for successful drug release.
Despite challenges caused by COVID-19, M&A activity in life sciences is recovering well.
Intelligent analytical tools detect impurities in small-molecule drug ingredients.
Okra gum serves as a polymer for oral drug formulations.
Microbial experts should employ proactive practices on the manufacturing floor.
Next Big COVID Challenge: Vaccines for Little Kids
Pharma strategizes to reduce its environmental footprint while optimizing output.
September 24, 2021
Researchers in China report test results for a microneedle patch for COVID-19 vaccine delivery.
Biden outlines a plan to end the pandemic in a virtual global conference.
GSK has received a positive recommendation from the EMA’s CHMP for Nucala (mepolizumab) to be used as a treatment in three additional eosinophil-driven diseases.
The first part of the 2021 CPhI Annual Report has been published and predicts a strong outlook for CDMOs over the next few years.
The organizers of Pharmapack Europe have released the results of its global drug delivery and packaging survey, demonstrating the continuation of the United States’ lead in innovation.
Celltrion Group has been granted approval for regdanvimab (CT-P59) to be used as a treatment for COVID-19 by the Korean Ministry of Food and Drug Safety (MFDS).
ProductLife Group (PLG) and Juuka Advisory have teamed up to form a new consulting offering, ProductLife Consulting.
September 23, 2021
The first and only approved antibody-drug conjugate for the treatment of recurrent or metastatic cervical cancer with disease progression on or after chemotherapy receives accelerated approval by FDA.
Boehringer Ingelheim to develop novel cancer therapies by leveraging Abexxa’s breakthrough antibody-based drugs.
In an amendment to their existing contract manufacturing agreement, Celsian and Poly Pharm expand GEN-1 program collaboration to add clinical and commercial batches of investigational vaccine.